Five things to know:
1. Fourth quarter sales were up 11.8% year-over-year with $5.8 billion. Full-year sales were $20.5 billion, an 11.1% increase from 2022.
2. Orthopedic sales in the fourth quarter were $2.4 billion, an 11% increase year-over-year. Hip sales were $414 million, and knee sales were $630 million.
3. Spine sales in the fourth quarter were $318 million. For the full year, spine sales were $1.2 billion.
4. Full year orthopedic sales were $8.7 billion, up 10.5% compared to 2022. Medsurg and Neurotechnology sales in 2023 were $11.8 billion, up 11.5% compared to 2022.
5. Stryker expects to see 7.5% to 9% increases in 2024 revenue compared to 2023. This is based on procedural volumes, demand for capital products and “stabilizing macro-economic
environment,” according to a news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
